Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs?

Clinical Severity and Complexity Due to the asymptomatic presentation in both the control and subclinical BPH groups, the ZIS remained constant at 11, resulting in highly significant differences when compared to the clinical BPH (17, IQR: 14–19, p ≤ 0.001) and BPH-Prostatitis (20, IQR: 17–25.5, p ≤ 0.001) groups.

also in 132,142 other papers

CPSE showed a trend toward predicting structural alterations (OR = 1.227, B = 0.204, p = 0.069) and was associated with larger stippled areas, increased prostatic volume, and larger cysts/abscesses (all p ≤ 0.001).

also in 53,322 other papers